Specialty modalities

Customized Solutions with an Integrated Approach

At Veranova, our extensive experience in specialized and complex API development enables the delivery of customized solutions across a wide range of specialty modalities. Spanning research and development to commercial-scale GMP production, our capabilities cover four key areas:

• Drug Conjugates & Linkers
• Polyethylene Glycols (PEGs) & Lipids
• Proteolysis Targeting Chimeras (PROTACs)
• Nucleotides, Oligonucleotides and Peptides (TIDES).

Veranova’s strength lies in an integrated approach which incorporates our expertise in chemical process development, all-scale manufacturing, and process optimization. Dedicated to achieving optimal results for our customers, we provide access to state-of-the-art process and analytical development labs, isolator suites for manufacture of highly potent compounds, lab to commercial scale chromatography, and full analytical support.

PEGs & Lipids

Our PEGs & Lipids capabilities focus on enhancing drug solubility, physical properties, and supporting formulation strategies that may influence pharmacokinetics. Veranova has extensive experience in the custom synthesis of PEG and lipid drug linkers and modifiers. Leveraging our expertise in solid state science and particle engineering, we offer comprehensive optimization, including unique paths to develop ionic cocrystals and improve drug purity and solubility.

Discover our PEGs & Lipids capabilities

TIDES

Veranova offers end-to-end support for custom nucleosides and activated monomers, oligonucleotides, peptides, and drug modifiers. Veranova can synthesize complex molecules utilizing liquid phase, solid phase, and/or fragment approach. Our purification and finishing capabilities extend to all-scale chromatography, thin film evaporation, spray drying, and crystallization. With over 10 years of experience, Veranova is a trusted partner for high-quality, cost-effective TIDES development and manufacturing.

Learn more about TIDES